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Background: Hwangryunhaedok-tang (HHT) is a traditional herbal medicine that is used for the treatment of
fever, inflammation, gastritis, and hypertension. In this study, we performed simultaneous determination of
the five components, geniposide (1), baicalin (2), coptisine (3), palmatine (4), and berberine (5) in HHT by
using a high-performance liquid chromatography–photodiode array (HPLC–PDA) analysis. We also evaluated
the antioxidative activity of HHT and compounds 1–5 by measuring their effects on low-density lipoprotein (LDL)
oxidation and antiproliferative abilities in vascular smooth muscle cells (VSMCs).
Methods: Five compounds were separated within 40 min by using a Gemini C18 column (temp. 35°C; two-component
gradient elution; flow rate 1.0 mL/min; detector 240 and 277 nm). The activities of HHT and compounds 1–5
were tested with the radical scavengers 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
and 2,2-diphenyl-1-picrylhydrazyl, in thiobarbituric acid reactive substance assays, and in relative electrophoretic
mobility assays using CuSO4-induced LDL oxidation systems. The antiproliferative effects of samples on platelet-derived
growth factor (PDGF)-induced VSMC proliferation were studied by using a cell proliferation assay.
Results: Regression analysis of the five major compounds showed good linearity (r2≥ 0.9997) in different concentration
ranges. The recoveries of the five compounds were in the range 86.31–110.78%, with relative standard deviations
below 2.1%; those of intra- and interday precision were 0.04–3.78% and 0.04–1.69%, respectively. HHT reduced
the oxidation properties of LDL induced by CuSO4 and inhibited cell proliferation in PDGF-treated VSMCs. Among
the five components, compound 2 could effectively suppress LDL oxidation and PDGF-induced VSMC proliferation.
Conclusions: The established HPLC–PDA method will help to improve quality control of HHT. The results demonstrate
that HHT has antiatherosclerotic activity and that it functions by modulating LDL oxidation and VSMC proliferation. The
effects of HHT may be attributed, at least I part, to compound 2.
Keywords: Simultaneous quantification, Hwangryunhaedok-tang, Antiatherosclerosis effect, HPLC–PDA, Traditional
Korean medicineBackground
Traditional herbal formulas are generally composed
of various herbs and have been used for the preven-
tion of and therapy for a variety of diseases for thou-
sands of years. Moreover, because herbal medicines
tent to have a mild effect and few side effects, many
people are becoming increasingly interested in traditional* Correspondence: hkshin@kiom.re.kr
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unless otherwise stated.herbal medicines [1-4]. Hwangryunhaedok-tang (HHT) is
a traditional Korean herbal medicine consisting of four
medicinal herbs, Coptidis Rhizoma, Scutellariae Radix,
Phellodendri Cortex, and Gardeniae Fructus in 1:1:1:1
proportions and is called Orengedokuto in Japan and
Hwanglianjiedu-tang in Chinese [5]. HHT has been used
clinically for the treatment of various symptoms including
inflammatory diseases [6,7], gastrointestinal disorders [8],
diabetes mellitus [9], brain injury [10-12], and acute liver
injury [13,14]. Recently, the preventative effect of HHT on
atherosclerosis was reported in models in vivo [15].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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HHT has not yet been thoroughly elucidated. In this
study, we investigated the antioxidant effects of HHT on
low-density lipoprotein (LDL) and antiproliferative effect
on vascular smooth muscle cells (VSMCs), which are
key atherosclerotic events [16,17]. Furthermore, chro-
matographic analysis was performed by using a high-
performance liquid chromatography–photodiode array
(HPLC–PDA) system to enable the simultaneous quanti-
fication of five major compounds, geniposide (1) in
Gardeniae Fructus, baicalin (2) in Scutellariae Radix,
and coptisine (3), palmatine (4), and berberine (5) in




The four crude herbs that make up HHT, Coptidis
Rhizoma, Scutellariae Radix, Phellodendri Cortex, and
Gardeniae Fructus, were purchased from Omniherb
(Yeongcheon, Korea) and HMAX (Jecheon, Korea). The
origin of each herbal medicine was taxonomically con-
firmed by Prof. Je Hyun Lee, Dongguk University,
Gyeongju, Korea. Voucher specimens (2008–KE20–1
through KE20–4) have been deposited at the HerbalFigure 1 Chemical structures of the compounds 1–5 found in HHT.Medicine Formulation Research Group, Korea Institute
of Oriental Medicine.
Chemicals and reagents
Compounds 1–5 (all purity ≥ 98.0%, Figure 1) were pur-
chased from Wako (Osaka, Japan). The HPLC-grade re-
agents methanol, acetonitrile, and water were obtained
from J.T. Baker (Phillipsburg, NJ, USA). Sodium dodecyl
sulfate (SDS) and phosphoric acid were obtained
from MP Biomedicals (Solon, OH, USA) and Daejung
Chemicals & Metals Co., Ltd (Daejeon, Korea), respect-
ively. 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
diammonium salt (ABTS) and 2,2-diphenyl-1-picrylhydra-
zyl (DPPH) were purchased from Sigma-Aldrich (St. Louis,
MO, USA). LDL and VSMC were purchased from
Biomedical Technologies (Stoughton, MA, USA) and
American Type Culture Collection (ATCC, Manassas, VA,
USA), respectively.
Apparatus and conditions
A Shimadzu LC-20A HPLC system (Shimadzu, Kyoto,
Japan) consisting of a system controller (CBM-20A), a
solvent delivery unit (LC-20AT), an on-line degasser
(DGU-20A3), a column oven (CTO-20A), a sample auto-
injector (SIL-20 AC), and a photodiode array (PDA)
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LCsolution software (version 1.24, Shimadzu, Kyoto,
Japan). The analytical column used for the separation of
the five components was a Phenomenex Gemini C18
(250 × 4.6 mm; particle size 5 μm, Torrance, CA, USA).
The mobile phases consisted of solvent A (10%, v/v, aceto-
nitrile in 0.2% SDS with phosphoric acid 200 μL/L) and
solvent B (acetonitrile). The gradient conditions of the two
mobile phases were: 10→ 40% B in 20 min, then 40→ 50%
B in 20 min, then 50→ 100% B in 10 min, then 100→ 10%
B in 5 min; the re-equilibrium time was 15 min. Column
temperature was maintained at 35°C. The analysis was car-
ried out at a flow rate of 1.0 mL/min, with PDA detection
at 240 nm for iridoid and alkaloids and 277 nm for flavon-
oid compounds. The injection volume was 10 μL.
Preparation of standard solutions
Each stock solution of reference compounds 1–5 was ac-
curately weighed and dissolved in methanol at a concen-
tration of 1,000 μg/mL. All the stock solutions were kept
at 4°C in a refrigerator until use and diluted to the appro-
priate concentration range to establish calibration curves.
Preparation of sample solutions
A decoction of HHT was prepared in our laboratory from
a mixture of chopped crude herbs. HHT was prepared as
described in Table 1 and extracted with distilled water at
100°C for 2 h under pressure (98 kPa) using an electric ex-
tractor (COSMOS-660; Kyungseo Machine Co., Incheon,
Korea). The extract was evaporated to dryness and freeze-
dried (17.1% yield). Lyophilized HHT extract (250 mg) was
dissolved in distilled water (25 mL), and then the solution
was passed through a 0.2 μm syringe filter (Woongki
Science, Seoul, Korea) before analysis by HPLC.
Calibration curves, range, limits of detection (LODs), and
of quantification (LOQs)
Each calibration curve was established by plotting peak
areas versus the concentration of standard solutions.
The concentration ranges were 7.81–500.00 μg/mL for
compounds 1 and 2, 1.56–50.00 μg/mL for compounds
3 and 5, and 4.69–300.00 μg/mL for compound 4. To
assess LOD and LOQ values, stock solutions of all refer-
ence compounds were diluted with methanol. The LODTable 1 Composition of HHT
Scientific name Latin name
Coptis chinensis Coptidis Rhizoma
Scutellaria baicalensis Scutellariae Radix
Phellodendron chinensis Phellodendri Cortex
Gardenia jasminoides Gardeniae Fructus
Total amountand LOQ values were determined as signal-to-noise (S/N)
ratios of 3 and 10, respectively.
Precision and accuracy
Intra- and interday precisions were determined by using
a standard addition method to prepare spiked samples,
employing both standards and controls. Precisions are
presented as the relative standard deviation (RSD) for
intra- and interday. The repeatability of the developed
method was evaluated by measuring six replicates of the
mixed standard solutions. The RSD values of peak areas
and retention times of each compound were used to
evaluate the repeatability of the developed HPLC
method. The test for recovery, which was carried out to
evaluate the accuracy of the methods, was performed by
adding three different concentrations (low, medium, and
high) of five reference standards to 200 mg of HHT sam-
ple. This test was conducted in triplicate and evaluated
by using the independently prepared calibration curves.
Determination of antioxidant activity
ABTS radical scavenging activity
The ABTS radical scavenging activity of the samples was
determined by using the method described Re et al. [18]
with slight modifications. Briefly, the ABTS radical cat-
ion was produced by reacting 7 mM ABTS solution with
2.45 mM potassium persulfate, then the solution was
stored in the dark at room temperature for 16 h. Prior
to the assay, the solution was diluted with phosphate
buffer saline (PBS, pH 7.4) to an absorbance of 0.7 at
734 nm. The ABTS•+ solution was then added to a 96-
well plate containing the test sample. After 5 min incu-
bation, the absorbance was immediately measured at
734 nm by using a microplate reader (Benchmark Plus,
Bio-Rad. Hercules, CA, USA). The extent of decolorization
was calculated as the percentage reduction of absorbance.
The scavenging capability of test compounds was calcu-
lated by using the equation:
ABTS radical scavenging activity %ð Þ
¼ 1 ‐ Asample=Acontrol
   100;
where Acontrol is the absorbance of the negative control
and Asample is the absorbance of the sample. RC50 valuesAmount (g) Supplier Origin
4.5 HMAX China
4.5 HMAX Jeongseon, Korea
4.5 HMAX China
4.5 Omniherb Muju, Korea
18.0
Figure 2 HPLC chromatogram of the standard mixture of five compounds with detection at 240 nm (A) and 277 nm (B), HHT sample
at 240 nm (C), and 277 nm (D). Geniposide (1), baicalin (2), coptisine (3), palmatine (4), and berberine (5).
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radical) were calculated from the concentration of sam-
ple required to reduce the absorbance by 50%.
DPPH radical scavenging activity
Radical scavenging activity of samples was determined
by using DPPH as a free radical by the method describedTable 2 Regression equation, linear range, correlation coeffic
Compound Linear range (μg/mL) Regression equationa
Geniposide 7.81 − 500.00 y = 14575.90x + 29400.74
Baicalin 7.81 − 250.00 y = 41028.20x + 12271.19
Coptisine 1.56 − 50.00 y = 45048.93x + 3766.28
Palmatine 4.69 − 300.00 y = 37568.06x + 15349.20
Berberine 1.56 − 50.00 y = 43158.92x + 4420.01
ay: peak area (mAU) of compounds; x: concentration (μg/mL) of compounds.
bLOD = 3 × signal-to-noise ratio.
cLOQ = 10 × signal-to-noise ratio.Moreno et al. [19] with some modifications. Briefly,
100 μL of various concentrations of sample was added
to 100 μL of DPPH solution (0.15 mM in ethanol) in a
96-well plate. After 30 min incubation in the dark at
room temperature, the absorbance was measured at
517 nm. Activity of scavenging (%) was calculated by
using the above formula.ient, LODs, and LOQs for marker compounds (n = 3)
















Geniposide 20.00 19.33 96.67 1.85 1.92
50.00 50.11 100.23 0.44 0.44
100.00 100.87 100.87 0.24 0.24
Baicalin 16.00 13.98 87.35 1.45 1.66
40.00 34.67 86.69 0.77 0.89
80.00 69.04 86.31 0.54 0.63
Coptisine 2.00 2.07 103.74 1.02 0.98
5.00 5.03 100.66 0.92 0.91
10.00 10.97 109.74 0.31 0.28
Palmatine 5.00 4.98 99.67 2.05 2.05
12.50 12.75 102.01 1.50 1.47
25.00 26.13 104.53 0.83 0.79
Berberine 2.00 1.99 99.47 1.18 1.19
5.00 5.44 108.76 1.82 1.67
10.00 11.08 110.78 0.87 0.78
aRecovery (%) = Detected amount / Spiked amount × 100.
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Oxidation of LDL by CuSO4
We examined the oxidation of LDL by CuSO4 by using
a previously described method [20]. LDL samples
(500 μg protein/mL, Biomedical Technologies, Stoughton,
MA, USA) were prepared at 37°C in a medium con-
taining 10 mM phosphate buffer (pH 7.4) and variousTable 4 Precision of the analytical results (n = 5)
















10.00 10.06concentrations of samples. After 5 min, the oxidation
was initiated by the addition of CuSO4 (25 μM). After
6 h oxidation, lipid peroxidation and electrophoretic
mobility of LDLs were measured as described below.
Determination of thiobarbituric acid reactive substance
(TBARS)
Lipid peroxidation of LDLs was estimated by determinng
the level of malondialdehyde (MDA) generated by using
a TBARS assay kit (BioAssay Systems, Hayward, CA,
USA) according to the manufacturer’s protocols [21].
After oxidation, 50 μg of LDLs was mixed with 200 μL
of thiobarbituric acid (TBA) and incubated at 100°C for
30 min. Upon completion of the reaction, the absorb-
ance at 535 nm was measured by using a microplate
reader.
Relative electrophoretic mobility (REM) assay
The electrophoretic mobility of LDLs was measured by
using agarose gel (0.8% agarose in TAE buffer) electro-
phoresis and Coomassie Brilliant Blue R-250 staining.
Electrophoresis was performed at 100 V for 30 min.
REM was defined as the ratio of the distances migrated
from the origin by oxLDL versus native LDL [22].
Vascular smooth muscle cell (VSMC) proliferation assay
Rat embryonic thoracic aorta smooth muscle-derived
A7r5 cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA) and
cultured as a monolayer culture at 37°C in a humidified
atmosphere of 5% CO2, 95% air in Dulbecco’s modifiedInterday
SD RSD (%) Detected Conc. (μg/mL) SD RSD (%)
0.14 0.73 19.52 0.22 1.13
0.14 0.29 49.95 0.12 0.24
0.04 0.04 100.12 0.04 0.04
0.08 0.46 16.09 0.16 1.00
0.10 0.24 40.09 0.15 0.37
0.06 0.07 79.94 0.05 0.06
0.01 0.45 2.02 0.01 0.62
0.07 1.59 4.72 0.04 0.77
0.04 0.35 10.14 0.02 0.16
0.03 0.68 4.91 0.04 0.81
0.05 0.41 12.33 0.05 0.43
0.02 0.08 25.10 0.03 0.12
0.07 3.78 1.89 0.03 1.69
0.04 0.87 4.98 0.05 1.10
0.03 0.31 10.03 0.02 0.22
Table 5 Amounts of the five marker compounds in the
HHT sample by HPLC (n = 3)
Compound Amount (mg/g) Sourcea
Mean SD (×10−1) RSD (%)
Geniposide 36.54 0.27 0.07 GF
Baicalin 30.24 0.72 0.24 SR
Coptisine 0.97 0.02 0.23 CR, PC
Palmatine 10.34 0.47 0.46 CR, PC
Berberine 1.35 0.02 0.16 CR, PC
aGF: Gardeniae Fructus, SR: Scutellariae Radix, CR: Coptidis Rhizoma,
PC: Phellodendri Cortex.
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ing 10% v/v fetal bovine serum (FBS, Gibco Inc., Grand
Island, NY, USA) and 1% penicillin–streptomycin (P/S).
Upon the attainment of 70–80% confluency, the cells
were incubated in serum-free DMEM containing 0.5%
bovine serum albumin for 20–24 h. Cytotoxicity and
proliferation assays were performed by using the Cell
Counting Kit-8 (CCK-8) as described by the manufac-
turer (Dojindo Laboratory, Kumamoto, Japan). Briefly,
cells were seeded onto 96-well plates and grown in a
final volume of 100 μL media per well. After treatment
as indicated in the text for 24 h, 10 μL of kit reagent was
added and the sample was incubated for an additional
3 h. Absorbance was measured at a wavelength of
450 nm by using a microplate reader.Figure 3 Effects of HHT and its five components on free radical scave
components (B), DPPH radical scavenging activity of HHT (C), and five com
and berberine (5). The data are mean values of three experiments ± SEM (nStatistical analysis
Statistical evaluation of the results was performed by
using one-way analysis of variance (ANOVA) followed by
Dunnett’s multiple comparison test by using GraphPad
InStat 3.05 software (GraphPad Software Inc, San Diego,
CA, USA).
Results and discussion
Optimization of chromatographic conditions
HPLC conditions such as column type, column tem-
perature, and mobile phases were optimized to achieve
the simultaneous separation of five analytes including
one iridoid, geniposide (1), one flavonoid, baicalin (2),
and three alkaloids, coptisine (3), palmatine (4), and ber-
berine (5). For the separation of compounds 1–5, col-
umns types (Phenomenex Gemini C18, Waters SunFire
C18, and OptimaPak C18 column), column temperatures
(30, 35, and 40°C), and various mobile phases (acids in-
cluding acetic acid and phosphoric acid and buffers such
as SDS and ammonium acetate, and organic solvent with
methanol and acetonitrile) were examined. By compar-
ing the peak shape, resolution, and baselines of the tar-
get compounds under different conditions, the most
satisfactory conditions were selected as Phenomenex
Gemini C18 column (250 × 4.6 mm, 5 μm) with gradient
elution of 10% v/v, acetonitrile in 0.2% SDS with phos-
phoric acid 200 μL/L–acetonitrile at 35°C for the
separation. Quantitation was achieved by using PDAnging activities. ABTS radical scavenging activity of HHT (A), five
ponents (D). Geniposide (1), baicalin (2), coptisine (3), palmatine (4),
= 3).
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277 nm for compound 2 based on retention time and UV
spectra compared with those of the standards. By using
the optimized HPLC conditions, the five analytes eluted
within 40 min and afforded good specificity without
interference from other components. Representative
HPLC chromatograms of standards and the HHT extract
are shown in Figure 2.
Regression equation, linearity, LOD, and LOQ
The regression equations were calculated by plotting the
peak area (y) versus concentration (x, μg/mL) of each
compound by using serial dilutions of the stock solution.
The correlation coefficients (r2) of compounds 1–5
were ≥ 0.9997, which showed good linearity. The LODs
and LOQs of the investigated compounds 1–5 were in
the range 0.34–0.87 and 1.12–2.89 μg/mL, respectively
(Table 2). The results showed that the developed HPLC
method was acceptable for the quantitative determin-
ation of compounds 1–5.Figure 4 Effects of HHT and its five components on Cu2+-induced LDL
incubated with CuSO4 for 6 h at 37°C. The TBARS levels (A: HHT, B: five com
of LDLs were measured by using a TBARS assay kit and agarose gel electro
palmatine (4), and berberine (5). The data are mean values of three experimAccuracy and precision
The recovery and precision of the developed method are
shown in Table 3. The recoveries of compounds 1–5
were in the range of 98.90–103.39% and the RSD values
were less than 2.53%. The repeatability of the developed
assay was evaluated based on peak responses and reten-
tion time by using the standard solution. The RSDs
of peak responses and retention time for repeatability
were < 0.44% and < 0.09% (data not shown), respectively,
indicating that the HPLC assay showed good repeatabil-
ity under the optimized conditions. The precisions of
intra and interday variation of compounds 1–5 in HHT
were less than 1.08% and 1.87%, respectively (Table 4).
The results described above indicate that the established
HPLC method was accurate and precise for the quanti-
tative determination of HHT extract.
HHT sample analysis
The five compounds in HHT were well separated by
using the developed HPLC method. The retention timesoxidation. Indicated concentrations of samples and LDLs were
ponents) and electrophoretic mobility (C: HHT, D: five components)
phoresis, respectively. Geniposide (1), baicalin (2), coptisine (3),
ents ± SEM (n = 3). ** P < 0.01 compared with the oxLDL group.
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were 5.363, 13.619, 31.642, 33.097, and 33.923 min, re-
spectively. The contents of compounds 1–5 in HHT
were 0.97–36.54 mg/g; the values are summarized in
Table 5.
Antioxidant activity of HHT and its components
To evaluate the antioxidant activity of HHT and of com-
pounds 1–5, their respective scavenging activities on
ABTS and DPPH radicals were tested. HHT showed
clear antioxidant properties, which were concentration
dependent (Figure 3A and C). The estimated concentration
required for 50% reduction (RC50) against ABTS and
DPPH was 25.76 ± 0.16 μg/mL and 92.97 ± 2.05 μg/mL,
respectively.Figure 5 Effects of HHT and its five components on PDGF-induced VS
VSMCs. Cells were incubated with the indicated concentrations for 24 h. Cel
effects of HHT and its five components in PDGF-treated VSMCs. Quiescent V
indicated concentrations of samples for 24 h and the proliferation was exam
(3), palmatine (4), and berberine (5). The data are mean values of three expe
# P < 0.05, ## P < 0.01 compared with the PDGF group.Compounds 1–5 were also tested in ABTS and DPPH
assays to determine their contribution to the antioxidant
property of HHT. In the ABTS assay, compounds 2–4
displayed RC50 values of 11.28 ± 0.21, 35.72 ± 0.54, and
163.17 ± 2.64 μM, respectively (Figure 3B). The scaven-
ging activity of compound 5 was 42% at 250 μg/mL con-
centration. In the DPPH assay, compound 2 had an
estimated RC50 value of 17.76 ± 0.15 μM (Figure 3D).
Effect of HHT and its components on Cu2+-mediated
oxidation of LDL
The effect of the compounds on Cu2+-mediated oxida-
tion of LDL was determined by two methods. First, the
degree of LDL oxidation was evaluated by the TBARS
assay. Lipid peroxidation was quantified by measuringMC proliferation. (A) Cytotoxicity of HHT and its five components in
l viability was determined by using the CCK-8 assay. (B) Antiproliferative
SMCs were stimulated with PDGF-BB (10 ng/mL) in the presence of the
ined by using the CCK-8 assay. Geniposide (1), baicalin (2), coptisine
riments ± SEM (n = 3). ** P < 0.01 compared with the control group,
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shown in Figure 4A and B, when LDL was incubated
with CuSO4 for 6 h, a significant increase in TBARS was
detected. In contrast, HHT significantly reduced, in a
concentration-dependent manner, the amount of TBARS
fromed (Figure 4A). Alteration of agarose gel electro-
phoretic mobility reflects the increase in negative charge
of LDL particles that occurred during oxidation [22].
When the oxidation was carried out in the presence of
HHT, the increased electrophoretic mobility of oxidized
LDL was significantly reduced (Figure 4C). As shown
in Figure 4B and D, compound 2 only reduced the
Cu2+-induced LDL oxidation.
Effect of HHT and its components on PDGF-induced VSMC
proliferation
To determine whether HHT and its five components
had any effect on cell viability, CCK-8 assays were per-
formed on cultured rat VSMCs treated with various con-
centrations of samples for 24 h. As shown in Figure 5A,
HHT and compounds 1 and 2 had no significant effect
on the viability of cells under the experimental conditions,
whereas compounds 3–5 induced cell proliferation.
VSMCs were pretreated with different concentrations of
HHT (125–500 μg/mL) and compounds 1–5 (50–200 μM)
followed by stimulation with PDGF-BB (10 ng/mL) for
24 h. HHT and compound 2 inhibited PDGF-BB-induced
proliferation of VSMCs in a concentration-dependent
manner (Figure 5B). The proliferative effects of compounds
3–5 on PDGF-treated VSMCs were accomplished by
themselves. These observations suggest that the inhibitory
effect of HHT on PDGF-induced VSMC proliferation was
partly attributed to compound 2.
Conclusions
A simple, reliable, and accurate HPLC–PDA method
was developed and validated for simultaneous separation
and determination of compounds 1–5 in the traditional
Korean herbal medicine, HHT. The developed method
showed good linearity, precision, and accuracy and is
therefore a suitable method with which to assess the
quality of HHT and its components for quality control
purposes. In this study, we have shown that HHT can re-
duce the oxidation of LDL and inhibit PDGF-induced
VSMC proliferation, which are key atherosclerotic events.
Compound 2, as one of the components in HHT, also ex-
hibits an antioxidant effect on LDL and an antiproliferative
effect on VSMCs. Although further studies are needed,
these observations suggest that HHT acts, to inhibit LDL
oxidation and suppress PDGF-induced VSMC prolifera-
tion, at least in part, through the effect of compound 2.
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